Clinical Trial Update: Prospective, Randomized Controlled Comparison of TERUMO SurFlash Plus Versus BD Insyte Autoguard in an Urban ED [NA]

View source ↗

Summary

A completed randomized trial comparing TERUMO SurFlash Plus to BD Insyte Autoguard in an urban emergency department; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Conditions
• Peripheral Catheterization Complications

Drugs mentioned

• BD Insyte Autoguard
• TERUMO SurFlash Plus (null)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Catheters, Catheterization, Peripheral | NA | Status: COMPLETED | Results posted: 2018-06-06